Cargando…

The effect of chemotherapy combined with recombination mutant human tumor necrosis factor on advanced cancer

BACKGROUND: Past studies suggested that tumor necrosis factor (TNF) assisted anti-tumor treatment and intensified the sensitivity of chemotherapy. However its clinical application has been curbed because of its low purity, high dosage, and strong toxicity. This research, through perspective random c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xing, Zhang, Xiang-fu, Zheng, Zhi-weng, Lu, Huishan, Wu, Xinyuan, Huang, Changmin, Wang, Chuan, Guang, Guoxiang
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC529310/ https://www.ncbi.nlm.nih.gov/pubmed/15485573 http://dx.doi.org/10.1186/1479-5876-2-33

Ejemplares similares

Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV
por: Xing, Peipei, et al.
Publicado: (2016)

Effect of neoadjuvant chemotherapy combined with hyperthermic intraperitoneal perfusion chemotherapy on advanced gastric cancer
por: CUI, HAI-BIN, et al.
Publicado: (2014)

Efficacy and safety of atezolizumab plus bevacizumab combined with hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma
por: Xin, Yujing, et al.
Publicado: (2022)

Efficacy of recombinant human adenovirus-p53 combined with chemotherapy for locally advanced cervical cancer: A clinical trial
por: Xiao, Jie, et al.
Publicado: (2017)

Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer
por: Fu, Tian, et al.
Publicado: (2020)

Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis
por: Feng, Li, et al.
Publicado: (2021)

Effects of Recombinant Circularly Permuted Tumor Necrosis Factor (TNF)-Related Apoptosis-Inducing Ligand (TRAIL) (Recombinant Mutant Human TRAIL) in Combination with 5-Fluorouracil in Human Colorectal Cancer Cell Lines HCT116 and SW480
por: Sun, Tongyou, et al.
Publicado: (2018)

Enhanced Antitumor Effect of Recombinant Human Tumor Necrosis Factor in Combination with Recombinant Human Granulocyte Colony‐stimulating Factor in BALB/c Mice
por: Maeda, Masahiro, et al.
Publicado: (1993)

Tumor Necrosis Factor Alpha: Implications of Anesthesia on Cancers
por: Tseng, Wei-Cheng, et al.
Publicado: (2023)

Corrigendum: A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study
por: Zhang, Ran, et al.
Publicado: (2022)

Clinical Effects of Xihuang Pill Combined with Chemotherapy in Patients with Advanced Colorectal Cancer
por: Yu, Dan, et al.
Publicado: (2017)

Selinexor in combination with standard chemotherapy in patients with advanced or metastatic solid tumors
por: Thein, Kyaw Z., et al.
Publicado: (2021)

Inflammatory properties of recombinant tumor necrosis factor in rabbit skin in vivo
Publicado: (1989)

A Potential Biomarker of Combination of Tumor Mutation Burden and Copy Number Alteration for Efficacy of Immunotherapy in KRAS-Mutant Advanced Lung Adenocarcinoma
por: Xiang, Luochengling, et al.
Publicado: (2020)

Conversion therapy for advanced gastric cancer with trastuzumab combined with chemotherapy: A case report
por: Xiao, Shuo-Meng, et al.
Publicado: (2018)

Antitumor Effect of Recombinant Human Interleukin‐1β Alone and in Combination with Natural Human Tumor Necrosis Factor‐α
por: Ohkura, Mitsuhiro, et al.
Publicado: (1990)

Tumor necrosis factor is dispensable for the success of immunogenic anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Combination chemotherapy for advanced colorectal cancer
por: Mason, M, et al.
Publicado: (2003)

Molecular and Biochemical Characterization of Recombinant Guinea Pig Tumor Necrosis Factor-Alpha
por: Dirisala, Vijaya R., et al.
Publicado: (2015)

Case report: Brain metastasis necrosis with immune checkpoint inhibitors plus chemotherapy for advanced non-small cell lung cancer
por: Niu, Lishui, et al.
Publicado: (2022)

A single-center randomized controlled study of intraperitoneal hyperthermic chemoperfusion in combination of recombinant human tumor necrosis factor (TNF) in treatment of malignant ascites caused by advanced abdominal cancers
por: Wu, Lexia, et al.
Publicado: (2022)

Enhancement of Cytotoxicity of Cisplatin in vitro by Recombinant Human Tumor Necrosis Factor and/or Recombinant Human Interferon‐α, β and ‐γ
por: Kim, Chang‐Min, et al.
Publicado: (1989)

Cyclical Combination Chemotherapy in Advanced Breast Cancer
por: Edelstyn, G. A., et al.
Publicado: (1973)

Elemene-containing hyperthermic intraperitoneal chemotherapy combined with chemotherapy for elderly patients with peritoneal metastatic advanced gastric cancer
por: Chen, Zhi-Xiong, et al.
Publicado: (2022)

Oxaliplatin-dacarbazine combination chemotherapy for the treatment of advanced soft tissue sarcoma of the limbs
por: Zong, Xiang-Yun, et al.
Publicado: (2009)

Induction of Tumor Necrosis Factor in Mice by Recombinant Human Macrophage Colony‐stimulating Factor
por: Sakurai, Takuma, et al.
Publicado: (1994)

A Recombinant Human Adenovirus Type 5 (H101) Combined With Chemotherapy for Advanced Gastric Carcinoma: A Retrospective Cohort Study
por: Zhang, Ran, et al.
Publicado: (2021)

Let-7 Sensitizes KRAS Mutant Tumor Cells to Chemotherapy
por: Dai, Xin, et al.
Publicado: (2015)

Characterization of a Novel Human Tumor Necrosis Factor‐α Mutant with Increased Cytotoxic Activity
por: Masegi, Tsukio, et al.
Publicado: (1995)

Safety and Feasibility of Esophagectomy Following Combined Immunotherapy and Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score Matching Analysis
por: Hong, Zhi-Nuan, et al.
Publicado: (2022)

Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment
por: Däster, Silvio, et al.
Publicado: (2016)

Pooled analysis of the clinical benefit of cyclooxygenase-2 inhibitors combined with chemotherapy in advanced non-small cell lung cancer
por: Zheng, Wei, et al.
Publicado: (2019)

Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
por: Cheng, Yue-Juan, et al.
Publicado: (2018)

Efficacy and safety analysis of chemotherapy combined with immunotherapy compared with standard chemotherapy for advanced biliary tract malignant tumors
por: Zhang, Zhengfeng, et al.
Publicado: (2023)

Combination of EGFR-TKIs with chemotherapy versus chemotherapy or EGFR-TKIs alone in advanced NSCLC patients with EGFR mutation
por: Wen, Miaomiao, et al.
Publicado: (2018)

Regional Hyperthermia Combined with Chemotherapy in Advanced Gastric Cancer
por: Fang, Hongming, et al.
Publicado: (2019)

Combination treatment of an IDH1 inhibitor with chemotherapy in IDH1 mutant acute myeloid leukemia
por: Gupta, Charu, et al.
Publicado: (2020)

Attachment of Histidine Tags to Recombinant Tumor Necrosis Factor-Alpha Drastically Changes Its Properties
por: Fonda, Irena, et al.
Publicado: (2002)

Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
por: Wu, Chunrong, et al.
Publicado: (2018)

Clinical effect and safety of targeted therapy combined with chemotherapy in the treatment of patients with advanced colon cancer
por: Zhang, Tao, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hh0qqsrfn60euas9be17anse90